TrialAdvances in therapy2026

Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment Comparison.

John Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.